Researchers will test the drugs against the disease after finding prostate cancer cells were more likely to duplicate and ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

There is a shadow disease that often lurks unnoticed, growing quietly within a man’s body which is hidden behind the mundane routine of daily life, masked by ag ...

Clinical data presented at ASCO 2025 showed an objective response rate (ORR) of 63% among all patients, with a median progression-free survival (PFS) of 7.7 months. Responses were seen across ...

Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 3.7% in the afternoon session after the company signed ...

Leuprorelin acetate, a medicine approved in the U.S. for prostate cancer, may slow the progression of SMA type SBMA, ...

I was one in eight. One in eight men will be diagnosed with prostate cancer in their lifetime. Nah, I was one in six. One in ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early ...

The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...

Cliff Richard, 85, said in an interview with “Good Morning Britain” that he was diagnosed with prostate cancer in 2024 after a health check for his insurance before a tour to Australia and New Zealand ...

LONDON -- British pop star Cliff Richard said Monday he has been given the all-clear after treatment for prostate cancer. The ...